Related references
Note: Only part of the references are listed.Lenalidomide Maintenance for High-Risk Multiple Myeloma after Allogeneic Hematopoietic Cell Transplantation
Melissa Alsina et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Regulatory T cells in cancer immunotherapy
Hiroyoshi Nishikawa et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
Adoptive T-cell therapy for hematological malignancies using T cells gene-modified to express tumor antigen-specific receptors
Hiroshi Fujiwara
INTERNATIONAL JOURNAL OF HEMATOLOGY (2014)
Ex vivo detection of CD8 T cells specific for H-Y minor histocompatibility antigens in allogeneic hematopoietic stem cell transplant recipients
Ryotaro Nakamura et al.
TRANSPLANT IMMUNOLOGY (2014)
New ways to separate Graft-versus-Host Disease and Graft-versus-Tumour effects after allogeneic haematopoietic stem cell transplantation
Eleni Kotsiou et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans
Daisuke Sugiyama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Dissecting graft-versus-leukemia from graft-versus-host-disease using novel strategies
E. H. Warren et al.
TISSUE ANTIGENS (2013)
Repetitive peptide boosting progressively enhances functional memory CTLs
Kendra Smyth et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantation
Marie Bleakley et al.
EXPERT REVIEW OF HEMATOLOGY (2012)
Functional differences between low- and high-affinity CD8+ T cells in the tumor environment
Rinke Bos et al.
ONCOIMMUNOLOGY (2012)
Selectively T Cell-Depleted Allografts from HLA-Matched Sibling Donors Followed by Low-Dose Posttransplantation Immunosuppression to Improve Transplantation Outcome in Patients with Hematologic Malignancies
Stephan Mielke et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantation
Yoshihiro Inamoto et al.
BLOOD (2011)
Preculture of PBMCs at high cell density increases sensitivity of T-cell responses, revealing cytokine release by CD28 superagonist TGN1412
Paula S. Roemer et al.
BLOOD (2011)
Donor immunization with WT1 peptide augments antileukemic activity after MHC-matched bone marrow transplantation
Holbrook E. Kohrt et al.
BLOOD (2011)
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation.
Ted A. Gooley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia
Katayoun Rezvani et al.
BLOOD (2009)
WT1 peptide-specific T cells generated from peripheral blood of healthy donors: possible implications for adoptive immunotherapy after allogeneic stem cell transplantation
G. Weber et al.
LEUKEMIA (2009)
Characterizing and optimizing immune responses to leukaemia antigens after allogeneic stem cell transplantation
Katayoun Rezvani et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2008)
Therapy of chronic graft-versus-host disease
Mukta Arora
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2008)
A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique
Stephan Mielke et al.
BLOOD (2008)
Graft-versus-leukemia effects of transplantation and donor lymphocytes
Hans-Jochem Kolb
BLOOD (2008)
Selective Depletion of Alloreactive T Lymphocytes Using Patient-Derived Nonhematopoietic Stimulator Cells in Allograft Engineering
Marion Nonn et al.
TRANSPLANTATION (2008)
Targeting minor histocompatibility antigens in graft versus tumor or graft versus leukemia responses
Xin Feng et al.
TRENDS IN IMMUNOLOGY (2008)
Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies
Katayoun Rezvani et al.
BLOOD (2008)
Graft-versus-leukemia effects associated with detectable Wilms tumor-1-specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia
Katayoun Rezvani et al.
BLOOD (2007)
Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8+ T cells
Claudia Wrzesinski et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Hematopoietic stem cell recipients do not develop post-transplantation immune tolerance to antigens present on minimal residual disease
Amanda Martinelli Natzke et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Functional HY-specific CD8(+) T cells are found in a high proportion of women following pregnancy with a male fetus
Karen P. Piper et al.
BIOLOGY OF REPRODUCTION (2007)
A novel source of viable peripheral blood mononuclear cells from leukoreduction system chambers
Allan B. Dietz et al.
TRANSFUSION (2006)
Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation
Alison W. Loren et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
T-cell responses directed against multiple HLA-A*0201-restricted epitopes derived from Wilms' tumor 1 protein in patients with leukemia and healthy donors: Identification, quantification, and characterization
K Rezvani et al.
CLINICAL CANCER RESEARCH (2005)
Cancer/testis antigens, gametogenesis and cancer
AJG Simpson et al.
NATURE REVIEWS CANCER (2005)
Selective depletion strategies in allogeneic stem cell transplantation
S Mielke et al.
CYTOTHERAPY (2005)
Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy
RM Verdijk et al.
BLOOD (2004)
Minor histocompatibility antigens as targets of cellular immunotherapy in leukaemia
JHF Falkenburg et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2004)
Expansion and activation of minor histocompatibility antigen HY-specific T cells associated with graft-versus-leukemia response
A Takami et al.
BONE MARROW TRANSPLANTATION (2004)
Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation
K Rezvani et al.
BLOOD (2003)
Prospects for immunotherapy of malignant disease
EC Morris et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
Overexpressed differentiation antigens as targets of graft-versus-leukemia reactions
JJ Molldrem et al.
CURRENT OPINION IN HEMATOLOGY (2002)
Minor histocomplatibility antigens as targets of graft-versus-leukemia reactions
JHF Falkenburg et al.
CURRENT OPINION IN HEMATOLOGY (2002)
CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia
C Scheibenbogen et al.
BLOOD (2002)
T cell homeostatic proliferation elicits effective antitumor autoimmunity
W Dummer et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
The use of HLA-A*0201-transfected K562 as standard antigen-presenting cells for CD8(+) T lymphocytes in IFN-gamma ELISPOT assays
CM Britten et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Expression of the Thomsen-Friedenreich antigen and of its putative carrier protein mucin 1 in the human placenta and in trophoblast cells in vitro
U Jeschke et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2002)
Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia
JJ Molldrem et al.
NATURE MEDICINE (2000)